Understanding how a protein called DIMT1 affects blood cell health
Catalytic roles of RNA methyltransferase DIMT1
This research explores how a protein called DIMT1 helps our blood stem cells develop, as issues with similar proteins can lead to blood disorders.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11129857 on NIH RePORTER |
What this research studies
This project aims to understand the specific jobs of a protein called DIMT1 in the development of healthy blood cells. We know that problems with how ribosomes, the cell's protein factories, are built can lead to human blood disorders. Our early findings suggest that DIMT1 is crucial for the survival of blood stem cells, which are the building blocks for all blood cells. We are investigating how DIMT1's activity, both as an enzyme and as a structural support, impacts these vital cells. This work will help us learn more about how blood cells are formed and what goes wrong in certain blood conditions.
Who could benefit from this research
Good fit: This basic science research does not directly involve patient participation, but future clinical applications may benefit patients with hematopoietic disorders or Fanconi anemia.
Not a fit: Patients not currently experiencing hematopoietic disorders or related conditions would not directly benefit from this foundational research.
Why it matters
Potential benefit: If successful, this work could reveal new ways to understand and potentially treat human hematopoietic disorders, including conditions like Fanconi anemia.
How similar studies have performed: While the importance of rRNA modifications in hematopoiesis has been characterized in a few studies, the specific molecular function and detailed mechanism of DIMT1 in human hematopoiesis are largely unknown, making this a novel investigation.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Liu, Fange — University of Pennsylvania
- Study coordinator: Liu, Fange
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.